000			02067 a2200601 4500
005			20250515074228.0
264		0	_c20071011
008			200710s 0 0 eng d
022			_a1015-9770
024	7		_a10.1159/000104485 _2doi
040			_aNLM _beng _cNLM
100	1		_aCervera, A
245	0	0	_aThe BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy. _h[electronic resource]
260			_bCerebrovascular diseases (Basel, Switzerland) _c2007
300			_a242-6 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aCase-Control Studies
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aIntegrin alpha2beta1 _xgenetics
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins
650	0	4	_aMembrane Proteins _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aMinisatellite Repeats
650	0	4	_aOdds Ratio
650	0	4	_aPatient Compliance
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xgenetics
650	0	4	_aPlatelet Glycoprotein GPIb-IX Complex
650	0	4	_aPolymorphism, Genetic
650	0	4	_aProspective Studies
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSecondary Prevention
650	0	4	_aStroke _xdrug therapy
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTime Factors
650	0	4	_aTreatment Failure
700	1		_aTàssies, D
700	1		_aObach, V
700	1		_aAmaro, S
700	1		_aReverter, J C
700	1		_aChamorro, A
773	0		_tCerebrovascular diseases (Basel, Switzerland) _gvol. 24 _gno. 2-3 _gp. 242-6
856	4	0	_uhttps://doi.org/10.1159/000104485 _zAvailable from publisher's website
999			_c17165391 _d17165391